[in the FORM of pharmacogenomics Plugin] It is unclear to us how to define a "pharmacogenomics fact"

[ningyifan]

It is unclear to us how to define a "pharmacogenomics fact", and how much information can be packed into one annotation instead of multiple annotations. One annotation should only discuss one drug-biomarker pair. That is clear. However, if a statement discusses both increased metabolism and increased toxicity, should those be annotated in one statement, or should two statements be annotated? What is the granularity we want?

[rkboyce]

We will revisit this question after the pharmds finish the initial test set